about
Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.Harnessing RNAi nanomedicine for precision therapyIdentification of siRNA delivery enhancers by a chemical library screen.Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.Nanogel-Mediated RNAi Against Runx2 and Osx Inhibits Osteogenic Differentiation in Constitutively Active BMPR1A OsteoblastsCurrent development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.The delivery of therapeutic oligonucleotidesTherapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system.Lipid nanoparticles for gene delivery.Microfluidics: a transformational tool for nanomedicine development and production.Biomaterials in siRNA Delivery: A Comprehensive Review.Delivery of therapeutic RNA-cleaving oligodeoxyribonucleotides (deoxyribozymes): from cell culture studies to clinical trials.Development of Therapeutic dsP21-322 for Cancer Treatment.Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran.Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.Small Molecule T315 Promotes Casitas B-Lineage Lymphoma-Dependent Degradation of Epidermal Growth Factor Receptor via Y1045 Autophosphorylation.The Effect of Size and Shape of RNA Nanoparticles on Biodistribution.Intracellular release of rapamycin from poly (lactic acid) nanospheres modifies autophagy.Progress and challenges towards targeted delivery of cancer therapeutics.
P2860
Q26859021-24981E93-643A-401B-8D84-C2AAA1F43C53Q30366990-4D5338CE-911A-4D7E-9B83-AAF78FD0DA28Q33901933-528A4988-F446-4E52-82CE-EFE77320E95BQ35673875-CC9F4E19-C9DB-4FCC-AFFA-E042F8998B88Q35721260-B887811D-2A27-4F16-A2AE-C406A833900EQ36459323-1673B250-154A-4EAD-BC9E-27E33B567306Q36682824-60AF51C3-0694-45B9-A98C-1882E46D5DDEQ36784555-8EB63E71-BB8D-4271-8A48-BB71F4551962Q37210936-FA8CD6A3-F9FD-4C64-8C8E-81436454114EQ37330601-70A41C4D-1F99-4E9C-AC0F-537761F68C42Q38269555-D3AD5F6B-7DCD-47E0-B761-9B3877441BDCQ38918919-30A8856C-9F61-4447-99C6-8C8A1AC03ABFQ38971775-1A8DEB8E-5954-418C-BD43-2969A3195C82Q39021948-5137FF2E-78B5-44E0-BF39-D7CE69EBC115Q39390094-13802362-F22E-41EA-95EF-35CA4B178101Q47106501-D154D7B6-74C3-4EB3-9823-771A55357451Q47840447-9040F6EF-A3ED-466D-A6D6-E7DDE485CEA1Q48070194-756E7F48-1C74-499F-A7C8-1EEFF736C323Q50061940-08F87068-5038-449D-9045-D604C04E1B01Q51285765-FB86EF04-A9E7-4C0F-B9B4-BD80B23F7BCDQ52590993-54CFF520-3D6D-47D3-B13F-C3856C4454DC
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Advances in Lipid Nanoparticles for siRNA Delivery.
@en
type
label
Advances in Lipid Nanoparticles for siRNA Delivery.
@en
prefLabel
Advances in Lipid Nanoparticles for siRNA Delivery.
@en
P2093
P2860
P1433
P1476
Advances in Lipid Nanoparticles for siRNA Delivery.
@en
P2093
Pieter R Cullis
Yuen Yi C Tam
P2860
P304
P356
10.3390/PHARMACEUTICS5030498
P577
2013-09-18T00:00:00Z